Diagnosis of Fanconi Anemia: Mutation Analysis by Multiplex Ligation-Dependent Probe Amplification and PCR-Based Sanger Sequencing
Open Access
- 21 June 2012
- journal article
- research article
- Published by Hindawi Limited in Anemia
- Vol. 2012, 1-13
Abstract
Fanconi anemia (FA) is a rare inherited disease characterized by developmental defects, short stature, bone marrow failure, and a high risk of malignancies. FA is heterogeneous: 15 genetic subtypes have been distinguished so far. A clinical diagnosis of FA needs to be confirmed by testing cells for sensitivity to cross-linking agents in a chromosomal breakage test. As a second step, DNA testing can be employed to elucidate the genetic subtype of the patient and to identify the familial mutations. This knowledge allows preimplantation genetic diagnosis (PGD) and enables prenatal DNA testing in future pregnancies. Although simultaneous testing of all FA genes by next generation sequencing will be possible in the near future, this technique will not be available immediately for all laboratories. In addition, in populations with strong founder mutations, a limited test using Sanger sequencing and MLPA will be a cost-effective alternative. We describe a strategy and optimized conditions for the screening ofFANCA, FANCB, FANCC, FANCE, FANCF,andFANCGand present the results obtained in a cohort of 54 patients referred to our diagnostic service since 2008. In addition, the follow up with respect to genetic counseling and carrier screening in the families is discussed.Keywords
This publication has 65 references indexed in Scilit:
- How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and IsraelAmerican Journal of Medical Genetics Part A, 2011
- DNA interstrand crosslink repair and cancerNature Reviews Cancer, 2011
- Mutations of the SLX4 gene in Fanconi anemiaNature Genetics, 2011
- Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer familiesBreast Cancer Research and Treatment, 2008
- Cancer risks among BRCA1 and BRCA2 mutation carriersBritish Journal of Cancer, 2007
- PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 2006
- A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group MNature Genetics, 2005
- The DNA helicase BRIP1 is defective in Fanconi anemia complementation group JNature Genetics, 2005
- X-linked inheritance of Fanconi anemia complementation group BNature Genetics, 2004
- A novel ubiquitin ligase is deficient in Fanconi anemiaNature Genetics, 2003